Portugal has debuted a new cancer and neuroscience research center in Lisbon, reports the Associated Press. The facility was built by the Champalimaud Foundation, which began work four years ago. Portuguese businessman Antonio Champalimaud gave the foundation $688 million to complete the work and make the facility one of the best in the world, AP says. The foundation is now looking to recruit researchers from all over the world to work in the new center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.